Free Trial
NASDAQ:EPRX

Eupraxia Pharmaceuticals (EPRX) Stock Price, News & Analysis

Eupraxia Pharmaceuticals logo
$5.46 +0.08 (+1.39%)
As of 07/3/2025 03:16 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Eupraxia Pharmaceuticals Stock (NASDAQ:EPRX)

Key Stats

Today's Range
$5.30
$5.74
50-Day Range
$3.79
$5.84
52-Week Range
$2.20
$6.20
Volume
8,647 shs
Average Volume
13,337 shs
Market Capitalization
$196.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.00
Consensus Rating
Buy

Company Overview

Eupraxia Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
49th Percentile Overall Score

EPRX MarketRank™: 

Eupraxia Pharmaceuticals scored higher than 49% of companies evaluated by MarketBeat, and ranked 1663rd out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Eupraxia Pharmaceuticals has received a consensus rating of Buy. The company's average rating score is 3.20, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Eupraxia Pharmaceuticals has only been the subject of 2 research reports in the past 90 days.

  • Read more about Eupraxia Pharmaceuticals' stock forecast and price target.
  • Percentage of Shares Shorted

    0.62% of the float of Eupraxia Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Eupraxia Pharmaceuticals has a short interest ratio ("days to cover") of 13.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Eupraxia Pharmaceuticals has recently increased by 0.17%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Eupraxia Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Eupraxia Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.62% of the float of Eupraxia Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Eupraxia Pharmaceuticals has a short interest ratio ("days to cover") of 13.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Eupraxia Pharmaceuticals has recently increased by 0.17%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Eupraxia Pharmaceuticals has a news sentiment score of 1.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Eupraxia Pharmaceuticals this week, compared to 1 article on an average week.
  • Search Interest

    Only 1 people have searched for EPRX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
Receive EPRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

EPRX Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Eupraxia Pharma director buys as stock tests top of range
See More Headlines

EPRX Stock Analysis - Frequently Asked Questions

Eupraxia Pharmaceuticals' stock was trading at $3.17 at the beginning of the year. Since then, EPRX stock has increased by 72.4% and is now trading at $5.4650.

Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) released its quarterly earnings data on Tuesday, May, 6th. The company reported ($0.21) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.19) by $0.02.

Shares of EPRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Eupraxia Pharmaceuticals investors own include Aeterna Zentaris (AEZS), BlackBerry (BB), Bausch Health Cos (BHC), Bitfarms (BITF), Ballard Power Systems (BLDP), Cardiol Therapeutics (CRDL) and Fury Gold Mines (FURY).

Company Calendar

Last Earnings
5/06/2025
Today
7/04/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:EPRX
Previous Symbol
NASDAQ:EPRX
Fax
N/A
Employees
29
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$11.00
High Stock Price Target
$12.00
Low Stock Price Target
$9.00
Potential Upside/Downside
+101.3%
Consensus Rating
Buy
Rating Score (0-4)
3.20
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$25.50 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$196.52 million
Optionable
N/A
Beta
1.55
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:EPRX) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners